CellaVision AB (publ) (STO:CEVI)
Sweden flag Sweden · Delayed Price · Currency is SEK
124.40
+2.40 (1.97%)
May 25, 2026, 5:29 PM CET

CellaVision AB Revenue

CellaVision AB had revenue of 166.43M SEK in the quarter ending March 31, 2026, a decrease of -14.57%. This brings the company's revenue in the last twelve months to 730.59M, down -2.32% year-over-year. In the year 2025, CellaVision AB had annual revenue of 758.97M with 4.94% growth.

Revenue (ttm)
730.59M
Revenue Growth
-2.32%
P/S Ratio
4.06
Revenue / Employee
3.03M
Employees
241
Market Cap
2.97B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025758.97M35.75M4.94%
Dec 31, 2024723.22M45.93M6.78%
Dec 31, 2023677.29M37.95M5.94%
Dec 31, 2022639.34M73.79M13.05%
Dec 31, 2021565.55M94.11M19.96%
Dec 31, 2020471.44M9.67M2.09%
Dec 31, 2019461.77M96.96M26.58%
Dec 31, 2018364.81M55.50M17.94%
Dec 31, 2017309.31M44.27M16.70%
Dec 31, 2016265.04M25.65M10.71%
Dec 31, 2015239.39M22.47M10.36%
Dec 31, 2014216.92M37.07M20.61%
Dec 31, 2013179.85M10.34M6.10%
Dec 31, 2012169.51M14.11M9.08%
Dec 31, 2011155.40M23.76M18.05%
Dec 31, 2010131.64M22.66M20.80%
Dec 31, 2009108.97M8.53M8.49%
Dec 31, 2008100.44M25.88M34.71%
Dec 31, 200774.57M19.79M36.12%
Dec 31, 200654.78M15.76M40.39%
Dec 31, 200539.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Nolato AB9.37B
Vitrolife AB3.41B
MedCap AB2.18B
BICO Group AB1.49B
Xvivo Perfusion AB834.53M
C-Rad AB427.80M
Paxman AB344.91M
Devyser Diagnostics AB257.50M
Revenue Rankings